Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1497 (LINC01497) is a non-protein-coding RNA gene classified as a long intergenic non-coding RNA (lincRNA)[1][5]. LincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap any protein-coding genes[3][7]. They are involved in the modulation of gene expression, primarily by remodeling chromatin structure, regulating transcription at nearby (cis) or distant (trans) sites, and potentially contributing to RNA stabilization and genome architecture[3][7]. Most lincRNAs, including LINC01497, do not encode peptides or proteins and are thought to exert their biological effects through RNA-based mechanisms[3]. LINC01497 has been mapped in GWAS studies as being associated with intergenic regulatory variants but there is little to no direct evidence that it serves as a therapeutic target, or that it is directly involved in a specific disease mechanism at this time[5]. No drugs, clinical biomarkers, or notable safety considerations are currently associated with this RNA, as it is not a classical pharmacological or clinical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1497 (LINC01497).